Results

Total Results: 536 records

Showing results for "statin".
Users also searched for: statin

281. Archived: C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
     July 15, 2008 - loss, exercise, and smoking cessation can reduce serum CRP levels, 86-87 and lowering CRP levels with statin … mmol/L (<130 mg/dL) (median, 2.8 mmol/L [108 mg/dL]), and no other indication (such as diabetes) for statin … The length of follow-up was inadequate to fully evaluate the potential harms of aggressive statin therapy … Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. … C-reactive protein levels and outcomes after statin therapy. N Engl J Med . 2005;352:20-8.

282. Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/h5Tt4jScmQJeHeztmo93hu
     February 25, 2020 - Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task

283. Mental-Illness-Heart Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
     April 01, 2013 - 1 Comparative Effectiveness Review Number 105 Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness Executive Summary Background Serious mental illness (SMI) is defined generally as a major mental or behavioral disorder, causing substantial impairment in multiple areas …

284. Final Research Plan: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cognitive-impairment-older-adults
     June 12, 2025 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Cognitive Impairment in Older Adults: Screening June 12, 2025 Recommendations made by the USPSTF are independent of the U.S. government. …

285. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
     January 01, 2013 - Example: In a study assessing the risk of cancer in statin users, an active comparator group of patients … on glaucoma drugs was used to control for potential bias because statin users engage in more health-seeking

286. Final Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-kidney-disease-screening
     July 13, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Chronic Kidney Disease: Screening July 13, 2023 Recommendations made by the USPSTF are independent of the U.S. government. They should no…

287. Executive Summary: Person-Centered Preventive Healthcare: Prioritizing Clinical Preventive Services (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/research/person-centered-prevent-care-summary.pdf
     December 01, 2023 - Executive Summary: Person-Centered Preventive Healthcare: Prioritizing Clinical Preventive Services Executive Summary Person-Centered Preventive Healthcare: Prioritizing Clinical Preventive Services Prepared for Agency for Healthcare Research and Quality Center for Evidence and Practice Improvement …

288. EvidenceNOW: Oklahoma Cooperative | Agency for Healthcare Research and Quality
     www.ahrq.gov/evidencenow/projects/heart-health/about/cooperatives/oklahoma.html
     March 01, 2021 - EvidenceNOW: Oklahoma Cooperative EvidenceNOW: Advancing Heart Health in Primary Care is an initiative of the Agency for Healthcare Research and Quality (AHRQ) to transform health care delivery by building a critical infrastructure (Primary Healthcare Extension System) to help smaller primary care practices im…

289. Archived: Final Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
     June 15, 2008 - In 1 trial, neither the diabetes group nor the nondiabetes subgroup benefited from statin treatment in … reducing mortality or cardiovascular event rates, but the rate of nonstudy statin use was high in the … In 2 fair-quality trials, statin therapy did not significantly reduce the primary end point (coronary … Statin safety: a systematic review. Am J Cardiol 2006;97:52C-60C. … Statin-related adverse events: a meta-analysis. Clin Ther 2006;28:26-35.

290. C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/khUSqr94jqWPErt9ZRnQ95
     October 01, 2009 - exercise, and smoking cessation can re- duce serum CRP levels (86, 87), and lowering CRP levels with statin … mmol/L (�130 mg/dL) (median, 2.8 mmol/L [108 mg/dL]), and no other indica- tion (such as diabetes) for statin … The length of follow-up was inadequate to fully evaluate the potential harms of aggressive statin therapy … Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. … C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20-8.

291. Follow-up Practice Survey Codebook Including Core and Optional Items (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-post-intervention.pdf
     June 02, 2025 - practice uses clinical guidelines for management of patients at risk for cardiovascular disease (e.g., statin

292. S44 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - Indeed, both the statin policy trial and the coxib policy trial did not proceed because of controversies

293. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
     February 01, 2012 - Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=750 Published Online: February 2012 Comparative Effectiveness Research Review …

294. Final Progress Report: Demonstration of Quality Improvement of Medication Therapy Management Services (pdf file)
     www.ahrq.gov/sites/default/files/2024-12/doucette-report.pdf
     January 01, 2024 - example, a one-page TIP sheet could be sent to Pharmacy A about a patient who was not filling her statin

295. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
     April 18, 2012 - ] OR "Hydroxymethylglutaryl-CoA Reductase Inhibitors" [Pharmacological Action] OR statins[tiab] OR statin

296. Practice Survey (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/practice-survey-ny.pdf
     June 02, 2025 - site uses clinical guidelines for management of patients at risk for cardiovascular disease (e.g., statin

297. Recommendation: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-interventions
     September 18, 2018 - screening for abnormal blood glucose levels and type 2 diabetes, screening for high blood pressure, statin … screening for abnormal blood glucose levels and type 2 diabetes, 13 screening for high blood pressure, 14 statin … Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task

298. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nop5YpEpMybx_oNPKC76-X
     July 11, 2017 - recommendation statements, the USPSTF had recom- mended screening for high blood pressure,11 use of statin … abnormal blood glucose levels and type 2 diabetes mellitus, screening for high blood pressure, use of statin … Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task

299. Microsoft Word - finapps.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
     January 01, 2007 - Kidney Function Cardio- vascular Disease Qual Appl Hanzel, 200527 154/77 ≥70% 40 Aspirin, statin … A All patients received aspirin 325 mg/day and a statin to achieve LDL cholesterol <100 mg/dl. … A All patients received aspirin 325 mg/day and a statin to achieve LDL cholesterol <100 mg/dl.

300. Enhanced Medication Histories (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/enhancedmedhistories_102611comp.pdf
     October 01, 2011 - of annual lab monitoring for all medication groups (ACE-I/ARB, Digoxin, Diuretic, Anticonvulsant, Statin … , Fibrate, Glitazone, Nefazadone, Niacin • High CK (>500)—Statin, Fibrate • High TSH (>6)—Levothyroxine … of annual lab monitoring for all medication groups (ACE-I/ARB, Digoxin, Diuretic, Anticonvulsant, Statin … Potassium high, on ACE-I/ARB 31 1179 2.6% Creatinine high, on Metformin 16 548 2.9% CK high, on Statin … or Fibrate 7 1212 0.6% SGPT high, on Statin, Fibrate, Glitazone, Nefazadone, or Niacin 4 1254 0.3%